CDXS vs. FF, LXRX, AGEN, VNDA, EBS, XOMA, ACHV, RIGL, RGLS, and SGMO
Should you be buying Codexis stock or one of its competitors? The main competitors of Codexis include FutureFuel (FF), Lexicon Pharmaceuticals (LXRX), Agenus (AGEN), Vanda Pharmaceuticals (VNDA), Emergent BioSolutions (EBS), XOMA (XOMA), Achieve Life Sciences (ACHV), Rigel Pharmaceuticals (RIGL), Regulus Therapeutics (RGLS), and Sangamo Therapeutics (SGMO).
FutureFuel (NYSE:FF) and Codexis (NASDAQ:CDXS) are both small-cap oils/energy companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, community ranking, analyst recommendations, valuation and institutional ownership.
FutureFuel presently has a consensus price target of $0.80, suggesting a potential downside of 81.31%. Codexis has a consensus price target of $7.50, suggesting a potential upside of 121.89%. Given FutureFuel's higher possible upside, analysts clearly believe Codexis is more favorable than FutureFuel.
FutureFuel has higher revenue and earnings than Codexis. Codexis is trading at a lower price-to-earnings ratio than FutureFuel, indicating that it is currently the more affordable of the two stocks.
In the previous week, FutureFuel had 1 more articles in the media than Codexis. MarketBeat recorded 5 mentions for FutureFuel and 4 mentions for Codexis. FutureFuel's average media sentiment score of 0.87 beat Codexis' score of 0.13 indicating that Codexis is being referred to more favorably in the news media.
Codexis received 111 more outperform votes than FutureFuel when rated by MarketBeat users. However, 68.22% of users gave FutureFuel an outperform vote while only 61.28% of users gave Codexis an outperform vote.
44.6% of FutureFuel shares are owned by institutional investors. Comparatively, 78.5% of Codexis shares are owned by institutional investors. 40.9% of FutureFuel shares are owned by insiders. Comparatively, 2.1% of Codexis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
FutureFuel has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Codexis has a beta of 2.04, indicating that its share price is 104% more volatile than the S&P 500.
FutureFuel has a net margin of 5.86% compared to FutureFuel's net margin of -87.73%. Codexis' return on equity of 7.46% beat FutureFuel's return on equity.
Summary
FutureFuel beats Codexis on 11 of the 18 factors compared between the two stocks.
Get Codexis News Delivered to You Automatically
Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CDXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
